IDLogiq® Innovations Selected by FDA DSCSA Pilot Project Program to Address National Security of Drug Supply Chain

SANTA CLARA, Calif., May 15, 2019 /PRNewswire/ -- IDLogiq® innovations have been selected by the Food and Drug Administration (FDA) for the Pilot Project Program under the Drug Supply Chain Security Act (DSCSA) to prototype and develop a system that can address the national security of the drug supply chain and future interoperability of secure electronic information exchange. "Counterfeit pharmaceuticals have been a growing market that created huge burdens for our industry and took away a million lives per year. We are honored to participate in the FDA Pilot Program to combat counterfeiting" says Kelly Nguyen, Founder and CEO of IDLogiq. IDLogiq innovative approach meets and exceeds regulatory requirements with an end-to-end, easy-to-use, and patient-focused solution that include...

0 Comments

IDLogiq Selected as a Finalist in GS1

With GS1 calling for startups with new innovations and "disruptive technologies", which would be promoted in the Startup Lab, IDLogiq came to the call as a startup with these unique disruptive technologies.

0 Comments